072020 — Choong Ang Vaccine Laboratory Income Statement
0.000.00%
Last trade - 00:00
- KR₩103bn
- KR₩84bn
- KR₩42bn
- 82
- 55
- 59
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32,903 | 36,318 | 40,914 | 39,299 | 41,868 |
Cost of Revenue | |||||
Gross Profit | 13,952 | 16,846 | 19,033 | 18,795 | 21,534 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 30,190 | 32,287 | 36,373 | 35,016 | 34,894 |
Operating Profit | 2,713 | 4,031 | 4,541 | 4,283 | 6,974 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,082 | 3,313 | 6,401 | 4,807 | 7,479 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,854 | 3,164 | 7,602 | 4,044 | 5,998 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,854 | 3,164 | 7,602 | 4,044 | 5,998 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,854 | 3,164 | 7,602 | 4,044 | 5,998 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 309 | 402 | 717 | 415 | 635 |
Dividends per Share |